Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 265.9 -3.05 (-1.13%) Market Cap: 34.30 Bil Enterprise Value: 33.17 Bil PE Ratio: 0 PB Ratio: 1,063.60 GF Score: 78/100

Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Apr 25, 2019 / 04:00PM GMT
Release Date Price: $87.88 (+2.94%)
Unidentified Company Representative

Good day, and welcome to the Alnylam Pharmaceuticals, Inc.'s Annual Meeting of Stockholders. I would now like to turn the conference over to Mr. Bonney, Chair of the Board. Please go ahead.

Michael W. Bonney
Alnylam Pharmaceuticals, Inc. - Chairman

Good morning, or good afternoon depending upon your time zone. Welcome to everyone who is participating online with us today. I would like to call to order the 2019 Annual Meeting of Stockholders of Alnylam Pharmaceuticals, Inc., which is being held virtually via the Internet.

I'd like to introduce the other directors who are present with us today for this annual meeting. Danny Ausiello; Marsha Fanucci; Margaret Hamburg; John Maraganore, who is also the company's Chief Executive Officer; Steve Paul; David Pyott; Colleen Reitan; Paul Schimmel; Amy Schulman; and Phil Sharp, constituting all members of our Board. Also with me here today are several members of the company's senior management team, including Akshay Vaishnaw, who's President of R&D, Yvonne Greenstreet, who's the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot